tiprankstipranks
Trending News
More News >
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Stock Statistics & Valuation Metrics

Compare
555 Followers

Total Valuation

Neurogene has a market cap or net worth of $307.78M. The enterprise value is $226.73M.
Market Cap$307.78M
Enterprise Value$226.73M

Share Statistics

Neurogene has 14,262,066 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,262,066
Owned by Insiders14.83%
Owned by Institutions0.36%

Financial Efficiency

Neurogene’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -25.53%.
Return on Equity (ROE)-0.24
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-25.53%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee8.64K
Profits Per Employee-702.28K
Employee Count107
Asset Turnover<0.01
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Neurogene is -5.34. Neurogene’s PEG ratio is 2.86.
PE Ratio-5.34
PS Ratio0.00
PB Ratio1.43
Price to Fair Value1.29
Price to FCF-3.99
Price to Operating Cash Flow-6.00
PEG Ratio2.86

Income Statement

In the last 12 months, Neurogene had revenue of 925.00K and earned -75.14M in profits. Earnings per share was -4.43.
Revenue925.00K
Gross Profit-2.32M
Operating Income-82.61M
Pretax Income-75.14M
Net Income-75.14M
EBITDA-71.89M
Earnings Per Share (EPS)-4.43

Cash Flow

In the last 12 months, operating cash flow was -69.73M and capital expenditures -1.52M, giving a free cash flow of -71.25M billion.
Operating Cash Flow-69.73M
Free Cash Flow-71.25M
Free Cash Flow per Share-5.00

Dividends & Yields

Neurogene pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.84
52-Week Price Change-48.61%
50-Day Moving Average15.21
200-Day Moving Average25.92
Relative Strength Index (RSI)57.63
Average Volume (3m)223.11K

Important Dates

Neurogene upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMay 9, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend Date

Financial Position

Neurogene as a current ratio of 20.84, with Debt / Equity ratio of 4.64%
Current Ratio20.84
Quick Ratio20.84
Debt to Market Cap<0.01
Net Debt to EBITDA1.73
Interest Coverage Ratio-6.88K

Taxes

In the past 12 months, Neurogene has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Neurogene EV to EBITDA ratio is -3.86, with an EV/FCF ratio of -3.88.
EV to Sales299.92
EV to EBITDA-3.86
EV to Free Cash Flow-3.88
EV to Operating Cash Flow-3.93

Balance Sheet

Neurogene has $292.60M in cash and marketable securities with $13.54M in debt, giving a net cash position of -$279.06M billion.
Cash & Marketable Securities$292.60M
Total Debt$13.54M
Net Cash-$279.06M
Net Cash Per Share-$19.57
Tangible Book Value Per Share$17.67

Margins

Gross margin is -1602.05%, with operating margin of -8930.27%, and net profit margin of -8123.68%.
Gross Margin-1602.05%
Operating Margin-8930.27%
Pretax Margin-8123.68%
Net Profit Margin-8123.68%
EBITDA Margin-7771.35%
EBIT Margin-8122.38%

Analyst Forecast

The average price target for Neurogene is $34.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$34.25
Price Target Upside58.71% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast
EPS Growth Forecast-140.77%

Scores

Smart Score4
AI Score33.5
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis